A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Regina Nethery to Retire as Vice President of Investor Relations

Tenet Healthcare Corporation (NYSE: THC) announced today that Regina Nethery, Vice President of Investor Relations, has chosen to retire from her position, effective at the end of 2021.

“We are extremely grateful to Regina for her thoughtful, strategic counsel and tremendous contributions to the organization throughout her tenure,” said Dan Cancelmi, Executive Vice President and Chief Financial Officer. “Regina’s recent recognition as one of the best Investor Relations professionals in Institutional Investor’s survey of Wall Street analysts is a testament to her exceptional contributions to the Company. We will miss Regina and wish her the best on her retirement.”

“I am pleased to have had the opportunity to share Tenet’s corporate strategy and its operational and financial progress with investors,” said Nethery. “I look forward to seeing Tenet’s further growth as I enter this next chapter of my life.”

“I echo Dan’s comments and have found Regina’s dedication, resilience and her balance in furthering our transparency to the market to be exceptional,” said Ron Rittenmeyer, Executive Chairman. “We wish her the very best in retirement.”

Tenet is working with Russell Reynolds Associates to conduct a national search for Nethery’s replacement.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy